Company intelligence / Profile preview

Redmile Group

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Redmile Group is a healthcare-focused investment organization founded in 2007 and based in San Francisco. It manages venture capital, private equity, and hedge fund investments primarily in biotechnology, therapeutics, life sciences, medical devices, and healthcare services. The firm has invested in numerous high-profile companies such as AlloVir, IGM Biosciences, Saluda Medical, Repare Therapeutics, ArcherDX, Augmedix and BioNTech. As of early 2020 the group had achieved at least 38 exits. Its assets under management are estimated at $1–1.4 billion as of Q1 2025.

Industry: Investors

Beyond the preview

Go deeper on Redmile Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redmile Group.

Explore the full profile